8.37
price down icon0.36%   -0.03
after-market Handel nachbörslich: 8.46 0.09 +1.08%
loading

Corvus Pharmaceuticals Inc Aktie (CRVS) Neueste Nachrichten

pulisher
Dec 11, 2025

Is Corvus Pharmaceuticals Inc a good long term investmentMarket Depth Overview & Budget Friendly Stock Tips - earlytimes.in

Dec 11, 2025
pulisher
Dec 10, 2025

What is Corvus Pharmaceuticals Inc (CRVS) Stock Return on Shareholders’ Capital? - setenews.com

Dec 10, 2025
pulisher
Dec 08, 2025

Corvus Pharmaceuticals (NASDAQ:CRVS) Trading 7.1% HigherWhat's Next? - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - The Manila Times

Dec 08, 2025
pulisher
Dec 08, 2025

Corvus Pharmaceuticals Reports Promising Phase 1 Data for Soquelitinib in Relapsed/Refractory T Cell Lymphoma at ASH Annual Meeting - Quiver Quantitative

Dec 08, 2025
pulisher
Dec 08, 2025

Corvus Pharmaceuticals Presents Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial - Yahoo Finance

Dec 08, 2025
pulisher
Dec 06, 2025

Corvus Pharma (CRVS) Stock Analysis Report | Financials & Insights - Benzinga

Dec 06, 2025
pulisher
Dec 06, 2025

Corvus Pharmaceuticals (NASDAQ:CRVS) Sets New 12-Month HighHere's What Happened - MarketBeat

Dec 06, 2025
pulisher
Dec 03, 2025

You might want to take a look at Corvus Pharmaceuticals Inc (CRVS) now - setenews.com

Dec 03, 2025
pulisher
Dec 03, 2025

Will Corvus Pharmaceuticals Inc. stock split again soonMarket Performance Report & Growth Focused Investment Plans - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Dec 02, 2025
pulisher
Dec 02, 2025

Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Down 8%Here's What Happened - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

Here's Why We're Not Too Worried About Corvus Pharmaceuticals' (NASDAQ:CRVS) Cash Burn Situation - Yahoo Finance

Dec 02, 2025
pulisher
Dec 02, 2025

Is Corvus Pharmaceuticals Inc. stock a buy before product launchesDividend Hike & Intraday High Probability Alerts - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 02, 2025
pulisher
Nov 26, 2025

Perhaps timely catching Corvus Pharmaceuticals Inc (CRVS) would be a good idea - Setenews

Nov 26, 2025
pulisher
Nov 26, 2025

Foresite Capital Management VI LLC Boosts Position in Corvus Pharmaceuticals, Inc. $CRVS - MarketBeat

Nov 26, 2025
pulisher
Nov 25, 2025

Corvus Pharmaceuticals: Trial Momentum Keeps Stock In Focus - RTTNews

Nov 25, 2025
pulisher
Nov 20, 2025

What risks investors should watch in Corvus Pharmaceuticals Inc. stockWeekly Trend Summary & Weekly Watchlist for Consistent Profits - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Corvus Pharmaceuticals Inc. stock reach Wall Street targetsPortfolio Growth Summary & Technical Buy Zone Confirmation - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is Corvus Pharmaceuticals Inc. stock affected by interest rate hikes2025 Geopolitical Influence & Consistent Profit Trading Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Corvus Pharmaceuticals Inc. stock supported by innovation pipeline2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What valuation multiples suggest for Corvus Pharmaceuticals Inc. stockRecession Risk & AI Forecast Swing Trade Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Corvus Pharmaceuticals Inc. stock momentum explainedWeekly Profit Report & Verified Swing Trading Watchlist - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Its Stock Has Paid Off Big Time For Corvus Pharmaceuticals Inc - Setenews

Nov 19, 2025
pulisher
Nov 17, 2025

BML Capital Management LLC Buys New Stake in Corvus Pharmaceuticals, Inc. $CRVS - MarketBeat

Nov 17, 2025
pulisher
Nov 16, 2025

Corvus Pharmaceuticals Inc. recovery potential after sell offPortfolio Update Summary & Safe Capital Growth Tips - newser.com

Nov 16, 2025
pulisher
Nov 14, 2025

Using RSI to spot recovery in Corvus Pharmaceuticals Inc.Earnings Growth Report & Long-Term Growth Portfolio Plans - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Combining price and volume data for Corvus Pharmaceuticals Inc.July 2025 Decliners & Reliable Momentum Entry Alerts - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Is Corvus Pharmaceuticals Inc. forming a bottoming baseTrade Risk Summary & Fast Moving Stock Watchlists - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

What drives Corvus Pharmaceuticals Inc stock priceEarnings Miss Alerts & Free Wealth Planning Blueprints - earlytimes.in

Nov 14, 2025
pulisher
Nov 14, 2025

Published on: 2025-11-28 13:27:18 - earlytimes.in

Nov 14, 2025
pulisher
Nov 13, 2025

What machine learning models say about Corvus Pharmaceuticals Inc.Weekly Profit Analysis & Reliable Breakout Stock Forecasts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

How to build a dashboard for Corvus Pharmaceuticals Inc. stockJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Is Corvus Pharmaceuticals Inc. stock a defensive play in 2025July 2025 Recap & Long-Term Safe Investment Ideas - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Should you wait for a breakout in Corvus Pharmaceuticals Inc.Index Update & Safe Entry Zone Tips - newser.com

Nov 13, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):